Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal disease.
| Image |  |
|---|---|
| Description | scientific article published on 5 November 2010 |
| Author/s | |
| Publication date | November 5, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |